Stockreport

Can Regeneron Squeeze Another Use Out Of Blockbuster Hopeful Dupixent? [Investor's Business Daily]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Related news Regeneron Pharmaceuticals ( REGN ) jumped Tuesday after its blockbuster hopeful Dupixent showed promise in treating nasal polyps. In afternoon trading on t [Read more]